CL
BCRX icon

Choreo LLC’s BioCryst Pharmaceuticals BCRX Stock Holding History

Choreo LLC’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
13,772
+233
+2% +$2.11K ﹤0.01% 1599
2026
Q1 		$129K Sell
13,539
-225
-2% -$1.75K ﹤0.01% 1529
2025
Q4 		$105K Buy
13,764
+20
+0.1% +$145 ﹤0.01% 1510
2025
Q3 		$104K Buy
13,744
+286
+2% +$2.38K ﹤0.01% 1507
2025
Q2 		$121K Buy
+13,458
New +$125K ﹤0.01% 1451
2025
Q1 		– Sell
-14,026
Closed -$106K – 1467
2024
Q4 		$106K Buy
+14,026
New +$106K ﹤0.01% 1496

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Choreo LLC's BCRX Position: Q2 2026 in Review

Choreo LLC increased its BioCryst Pharmaceuticals (BCRX) stake by 1.7% in Q2 2026, buying an estimated $2.11K and bringing the position to 13,772 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Choreo LLC first reported a position in BCRX in Q4 2024 and has held it in 6 quarters since. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Choreo LLC held 13,772 shares of BioCryst Pharmaceuticals worth $138K as of Q2 2026.
  • Choreo LLC bought 233 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $2.11K.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1599 holding.
  • Choreo LLC first reported a position in BioCryst Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.